BGSF, Inc. Closes on Divestiture of Its Professional Division in $99 Million All-Cash Deal

Stock Information for ESSA Pharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ESSA Pharma Inc.

BGSF, Inc. Reports Third Quarter 2025 Financial Results and Announced a Stock Buyback Plan
BGSF, Inc. Delays Timing of Its Fiscal 2025 Third Quarter Results and Earnings Conference Call
BGSF, Inc. Announces Timing of Fiscal 2025 Third Quarter Results and Earnings Conference Call
BGSF, Inc. Announces Additional Information Regarding Pending Special Cash Dividend of $2.00 Per Share
BGSF, Inc. Announces Special Cash Dividend of $2.00 Per Share
BGSF, Inc. Reports Second Quarter 2025 Financial Results
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPTN, BGSF, COOP, EPIX on Behalf of Shareholders
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate Merger of SPTN, BGSF, COOP, and EPIX

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.